COMMUNIQUÉS West-GlobeNewswire

Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
24/09/2026
Heidelberg site to lead GMP development of lactoperoxidase and glucose oxidase for Phase II clinical trials HEIDELBERG, Germany, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Belgian biopharmaceutical company Flen Health has [...]
Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress
24/09/2026
Final Phase 2a data from the BIRCH trial of BIOX-101 in acute intracerebral hemorrhage, selected for a Late-Breaking Science oral presentation New data show statistically significant improvements across multiple [...]
Carbios reports first-half 2026 results
24/09/2026
19 % reduction in operating expenses compared with the first half of 2025, reflecting the financial discipline of the Group Solid cash position of €48 million as of June 30, 2026, enabling Carbios to cover its operating [...]
Carbios présente ses résultats semestriels 2026
24/09/2026
Réduction des dépenses opérationnelles de 19 % par rapport au 1 er semestre 2025, reflétant la discipline financière du Groupe Solide position de trésorerie de 48 millions d’euros au 30 juin 2026, permettant à Carbios [...]
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
24/09/2026
Geneva, Switzerland, September 24, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for [...]
Strategic Transformation Supports Roquette’s H1 2026 Performance
24/09/2026
Strategic Transformation Supports Roquette’s H1 2026 Performance +9% turnover growth to €2,586 million and +18% Current EBITDA increase to €337 million. Performance was supported by favorable volume and mix effects, the [...]
La transformation stratégique soutient la performance de Roquette au premier semestre 2026
24/09/2026
La transformation stratégique soutient la performance de Roquette au premier semestre 2026 Croissance du chiffre d'affaires de +9 % à 2 586 M€ et progression de l'EBITDA Courant de +18 % à 337 M€. La performance a été [...]
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development
24/09/2026
OXFORD, United Kingdom and BURLINGTON, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Scancell Holdings plc (AIM: SCLP) (“ Scancell ”, or the “ Company ”), a late-stage clinical immuno-oncology company developing active [...]
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines
24/09/2026
BEIJING, Sept. 24, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company [...]
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026
24/09/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of [...]
EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect
24/09/2026
EssilorLuxottica and Meta further advance AI glasses category with new products revealed at Meta Connect The two companies introduce new line of audio AI glasses and next generation of Ray-Ban Meta, the world’s leading [...]
EssilorLuxottica et Meta continuent de développer la catégorie des lunettes IA avec de nouveaux produits, dévoilés lors de Meta Connect
24/09/2026
EssilorLuxottica et Meta continuent de développer la catégorie des lunettes IA avec de nouveaux produits, dévoilés lors de Meta Connect Les deux entreprises lancent une nouvelle gamme de lunettes IA audio et une [...]
Ozari Health Named Best Place to Buy Compounded Tirzepatide Online for 2026
23/09/2026
The New York telehealth platform's compounded tirzepatide program, priced at $125 per month all-in with two publicly named US-licensed 503A compounding pharmacies, leads a new MedicalResearch.com comparison of the best [...]
Elevar Therapeutics Announces FDA Approval of Lyrfigtu (Lirafugratinib) as Second-line Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement Treatment Option
23/09/2026
Lyrfigtu demonstrated a confirmed ORR of 46% and mDOR of 11.8 months, with a predictable and manageable safety profile CCA, also known as bile duct cancer, is diagnosed in about 8,000 people in the U.S. each year FORT [...]
Regina Skin Medical Introduces Preventive Medical Beauty Methodology Following Long-Term Skin Metabolism Studies
23/09/2026
HONG KONG, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Regina Skin Medical has announced the introduction of a new preventive medical beauty framework designed to address the root causes of chronic skin pigmentation, [...]
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
23/09/2026
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis FREMONT, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) [...]
Teva Releases Q3 2026 Aide Memoire
23/09/2026
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on [...]
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET
23/09/2026
TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2026 financial [...]
Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions
23/09/2026
Silver Spring, MD, Sept. 23, 2026 (GLOBE NEWSWIRE) -- A U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA- [...]

Pages